Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AIM ImmunoTech Inc. (HEB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -19.4-19.1-14.4-9.4-9.8-8.3-7.5-15.2
Depreciation and amortization   [+]0.30.80.70.80.90.91.10.9
Asset impairment charges   1.81.4     
Stock-based compensation  1.01.61.00.90.90.60.40.2
Change in working capital   [+]6.11.50.9-0.5-2.11.10.0-2.6
Other operating activities  -4.0-0.40.0-0.8-0.5-2.3-1.40.6
Cash from operations  -16.1-14.0-10.4-9.1-10.6-7.9-7.4-16.1
   
Capital expenditures   [+]-0.10.00.0-0.1-0.10.0-0.2-0.2
Purchases of intangible assets  -0.2-0.6-0.6-0.3-0.10.0-0.3-0.3
Sales of short-term investments, net   [+]7.4-0.2-8.6-5.8 2.83.46.8
Other cash from investing      0.2   
Cash from investing  11.0-0.6-9.2-6.10.12.72.96.4
   
Issuance of common stock, net  0.113.061.215.35.12.44.79.7
Financing costs      -0.4-0.1  
Other cash from financing   -4.9-4.71.13.91.70.00.0
Cash from financing  0.18.256.616.49.44.24.89.7
   
Free cash flow  -16.2-14.0-10.4-9.1-10.7-8.0-7.5-16.3
        Per share (diluted)  ($0.33)($0.29)($0.33)($2.51)($10.65)($0.28)($0.35)($0.83)
   
Cash paid for interest       0.1 0.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy